文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

地理信息系统在尼日利亚2017/2018年麻疹疫苗接种活动免疫服务提供中的应用

Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
PubMed 文献 · Vaccine · 2021-01-19

该研究报道了在尼日利亚北部各州2017/2018年麻疹疫苗接种活动中应用GIS生成选区地图进行微规划的过程与效果。GIS地图用于估算目标人口、设置接种点(确保距居民点一公里半径内)及团队配置,并经国家团队验证。结果显示GIS州运行目标人口更接近核实微规划,接种点过远作为未接种理由的比例低于非GIS南部州,且采样点中仅一安全受扰地区出现零剂次聚集。

要点

  • GIS生成选区地图用于麻疹疫苗接种活动微规划,含目标人口、接种点位置与团队配置。
  • GIS州运行目标人口更接近核实微规划,接种点过远作为未接种理由比例低于非GIS州。
  • GIS州竞选后调查采样点中仅一安全受扰地区出现零剂次接种聚集。

核心结论

  • 使用GIS生成的选区地图改善了选区微规划质量并优化了接种点布局,显著减少了竞选后覆盖调查中发现的零剂次聚集。

研究设计与样本

  • 研究为尼日利亚2017/2018年麻疹疫苗接种活动中应用GIS生成选区地图进行微规划的报告,覆盖北部各州,并与未使用GIS微规划的南部州进行比较。

主要发现

  • 应用GIS技术的北部州运行目标人口比非GIS技术州更接近核实微规划上的目标人口。
  • 超过90%的选区地图捕获了居民点、目标人口和接种点,但卡杜纳、卡齐纳和阿达马瓦州除外。
  • 在GIS选区地图州竞选后调查采样的所有普查区中,除博尔诺州一个存在安全问题者外,无一出现所调查儿童的零疫苗接种覆盖率。
  • 竞选后覆盖调查中,使用GIS生成选区地图的北部区域报告接种点太远作为儿童未接种理由的应答百分比低于未使用GIS微规划的南部区域该比率的一半。

临床怎么用

  • 在麻疹疫苗接种活动规划中,可使用GIS生成选区地图进行微规划,估算目标人口、设置接种点(确保距居民点一公里半径内)并配置团队。
  • 选区微规划应经标准检查表核实目标人口、居民点、团队数、接种点和每日实施工作计划的准确性与一致性,并经国家团队验证后投入使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As global effort is made towards measles elimination, the use of innovative technology to enhance planning for the campaign has become critical. GIS technology has been applied to track polio vaccination activities in Nigeria with encouraging outcomes. Despite numerous measles vaccination campaigns after the first catch up campaign in 2005, sub-optimal outcomes of previous measles supplemental immunization activities necessitated the use of innovative ideas to achieve better outcomes especially when planning for the 2017/2018 measles vaccination campaign. This led to the application of the use of the GIS technology for the Northern states in 2017/2018 campaign. This study is a report of what was achieved with the use of the GIS in the 2017/2018 measles vaccination campaign in Nigeria. METHODS: GIS generated ward maps were used for the microplanning processes for the 2017/2018 measles vaccination campaign. These ward maps had estimates of the target population by settlements, the number and location of vaccination posts ensuring that a vaccination post is sited within one-kilometer radius of a settlement, and the number of teams needed to support the vaccination campaign as well as the catchment area and daily implementation plans. The ward microplans were verified by checking for accuracy and consistency of the target population, settlements, number of teams, vaccination posts and daily implementation work plans using a standard checklist. The ward maps were deployed into use for the measles vaccination campaign after the state team driven validation and verification by the National team (Government and Partners) RESULTS: The Northern states that applied the GIS technology had a closer operational target population to that on the verified microplan than those of the non-GIS technology states. Greater than 90% of the ward maps had all that is expected in the maps - i.e settlements, target populations, and vaccination posts captured, except Kaduna, Katsina and Adamawa states. Of all enumeration areas sampled during the post-campaign survey in states with GIS ward maps, none had a zero-vaccination coverage of the surveyed children, with the exception of one in Borno state that had security issues. In the post campaign coverage survey, the percentage of responses that gave vaccination post being too far as a reason for non-vaccination of children in the Northern zones that used GIS generated ward maps was less than half the rate seen in the southern zones where the GIS microplanning was not used. CONCLUSION: The use of GIS-generated wards maps improved the quality of ward micro plans and optimized the placement of vaccination posts, resulting in a significant reduction in zero-dose clusters found during the post campaign coverage survey.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Oteri J, Idi Hussaini M, Bawa S, et al. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria. Vaccine. 2021. PMID: 33478790. doi:10.1016/j.vaccine.2021.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。